Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma

por Amdahl, Jordan, Chen, Lei, Delea, Thomas E.
Publicado 2016

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer

por Hagiwara, May, Delea, Thomas E., Cong, Ze, Chung, Karen
Publicado 2013

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2− Advanced Breast Cancer

por Stellato, Daniel, Thabane, Marroon, Eichten, Caitlin, Delea, Thomas E.
Publicado 2021

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom

por Amdahl, Jordan, Diaz, Jose, Sharma, Arati, Park, Jinhee, Chandiwana, David, Delea, Thomas E.
Publicado 2017

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia

por Hatswell, Anthony J., Thompson, Gwilym J., Maroudas, Penny A., Sofrygin, Oleg, Delea, Thomas E.
Publicado 2017

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease

por Mallya, Usha G., Boklage, Susan H., Koren, Andrew, Delea, Thomas E., Mullins, C. Daniel
Publicado 2017

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

por Delea, Thomas E., Zhang, Xinke, Amdahl, Jordan, Boyko, Diana, Dirnberger, Franziska, Campioni, Marco, Cong, Ze
Publicado 2019

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom

por Amdahl, Jordan, Manson, Stephanie C., Isbell, Robert, Chit, Ayman, Diaz, Jose, Lewis, Lily, Delea, Thomas E.
Publicado 2014

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada

por Delea, Thomas E., Weycker, Derek, Atwood, Mark, Neame, Dion, Alvarez, Fabián P., Forget, Evelyn, Langley, Joanne M., Chit, Ayman
Publicado 2017

Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease

por Ershler, William B., De Castro, Laura M., Pakbaz, Zahra, Moynahan, Aaron, Weycker, Derek, Delea, Thomas E., Agodoa, Irene, Cong, Ze
Publicado 2023

Administrative Claims Analysis of Utilization and Costs of Care in Health Plan Members With Atopic Dermatitis Who Had Prior Use of a Topical Corticosteroid and Who Initiate Therapy...

por Delea, Thomas E., Gokhale, Manjusha, Makin, Charles, Hussein, Mohamed A., Vanderpoel, Julie, Sandman, Timothy, Chang, Jane, Sung, Jennifer, Pinkston, Paul, Gause, Douglas, Jackson, J. Mark
Publicado 2007

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer

por Fasching, Peter A, Delea, Thomas E, Lu, Yen-Shen, De Boer, Richard, Hurvitz, Sara A, Moynahan, Aaron, Chandiwana, David, Lanoue, Brad, Hu, Huilin, Thuerigen, Astrid, O’Shaughnessy, Joyce
Publicado 2021